INVA
Innoviva, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +1.3% · neue Nettopositionen -5.3% · Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 246.52K | $5.22M | n/a | n/a |
| Q2 2026 | 104 | +3 | 60.75M | $1.34B | +7 | −5 |
| Q1 2026 | 105 | -1 | 60.91M | $1.40B | +5 | −7 |
| Q4 2025 | 107 | +1 | 64.49M | $1.28B | +2 | n/a |
| Q3 2025 | 19 | 0 | 37.28M | $672.57M | n/a | −1 |
| Q2 2025 | 17 | 0 | 33.81M | $670.62M | n/a | n/a |
| Q1 2025 | 14 | +1 | 14.22M | $254.33M | +1 | n/a |
| Q4 2024 | 13 | -1 | 11.88M | $203.26M | n/a | −1 |
| Q3 2024 | 13 | 0 | 9.24M | $175.70M | n/a | n/a |
| Q2 2024 | 13 | n/a | 8.36M | $134.81M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 9.46M | +3.5% | $172.30M | 0.0% | ▲ Add | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (passiv) | 7.39M | -0.6% | $130.41M | 0.0% | ▼ Trim | 2 | SEC ↗ ×8 |
| 3 | Renaissance Technologies ✦ | 4.63M | -3.6% | $83.83M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passiv) | 2.60M | +4.0% | $46.78M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Arrowstreet Capital ✦ | 2.36M | +38.0% | $43.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 6 | Marshall Wace ✦ | 1.65M | +23.9% | $30.14M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 1.64M | -17.5% | $29.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 1.68M | +3.2% | $29.04M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 9 | Morgan Stanley ✦ | 1.43M | n/a | $26.02M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 10 | Goldman Sachs Group ✦ | 1.20M | n/a | $21.98M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 987.02K | -31.4% | $18.01M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | D. E. Shaw & Co. ✦ | 735.73K | -28.0% | $13.43M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Two Sigma Investments ✦ | 522.24K | +57.4% | $9.53M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | JPMorgan Chase ✦ | 437.97K | n/a | $7.99M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 15 | AQR Capital Management ✦ | 302.47K | +53.7% | $5.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 16 | Gotham Asset Management ✦ | 112.75K | +33.6% | $2.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 72.46K | +4.2% | $1.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 37.31K | +7.5% | $680,937 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 19 | Wellington Management ✦ | 28.01K | +22.5% | $511,256 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Norges Bank | $1.38M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 283 Inhaber, 74.79M Anteile, $1.72B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.